According to Stratistics MRC, the Global Nephrostomy Devices Market is expected to grow at a CAGR of 8.0% during the forecast period. Factors such as growing incidence of kidney stone and rising incidence of ovarian cancer, bladder cancer and prostate cancer are propelling the market growth. However, alternative measures such as ureteral stenting is hampering the market growth.
Nephrostomy catheter is the most important option for drainage of an obstructed urine collecting system. It is generally inserted under local anesthetic, which works by temporarily diverting urine from place of blockade. Hydronephrosis is the common indication characterized by blockade of one or both the ureters, for which nephrostomy catheters are used.
By Product Type, Guidewires segment has a significant growth during the forecast period due to this devices are flexible and have other properties including kink resistance and pushability. Based on geography, North America has the largest market share during the forecast period due to the availability of highly skilled professionals and the occurrence of well-equipped healthcare infrastructure are some of the factors driving the market growth in this region.
Some of the key players profiled in the Nephrostomy Devices Market include Boston Scientific Corporation , Teleflex Incorporated, Cardinal Health Inc., Medi-globe Corporation, Argon Medical Devices, Inc., Merit Medical Systems, Inc., Angiodynamics Inc, Cook Medical, Olympus Corporation, Coloplast Group, BD and Medtronic Inc.
Product Types Covered:
• Sheath Dilators
• Nephrostomy Catheters
• Drainage Tubes
• Guidewires
• Other Product Types
End Users Covered:
• Ambulatory Surgical Centers
• Specialty Clinics
• Hospitals
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country level segments
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Nephrostomy Devices Market, By Product
7.1. Nephrostomy Devices Market, By Product, 2021-2028
7.1.1. Guidewires
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Drainage Tubes
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Nephrostomy Catheters
7.1.3.1. Market Revenue and Forecast (2016-2028)
7.1.4. Sheath Dilators
7.1.4.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global Nephrostomy Devices Market, By End-Use
8.1. Nephrostomy Devices Market, By End-Use, 2021-2028
8.1.1. Hospitals
8.1.1.1. Market Revenue and Forecast (2016-2028)
8.1.2. Emergency Clinics
8.1.2.1. Market Revenue and Forecast (2016-2028)
8.1.3. Ambulatory Surgical Centers (ASCs)
8.1.3.1. Market Revenue and Forecast (2016-2028)
Chapter 9. Global Nephrostomy Devices Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, By Product (2016-2028)
9.1.2. Market Revenue and Forecast, By End-Use (2016-2028)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, By Product (2016-2028)
9.1.3.2. Market Revenue and Forecast, By End-Use (2016-2028)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, By Product (2016-2028)
9.1.4.2. Market Revenue and Forecast, By End-Use (2016-2028)
9.2. Europe
9.2.1. Market Revenue and Forecast, By Product (2016-2028)
9.2.2. Market Revenue and Forecast, By End-Use (2016-2028)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, By Product (2016-2028)
9.2.3.2. Market Revenue and Forecast, By End-Use (2016-2028)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, By Product (2016-2028)
9.2.4.2. Market Revenue and Forecast, By End-Use (2016-2028)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, By Product (2016-2028)
9.2.5.2. Market Revenue and Forecast, By End-Use (2016-2028)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, By Product (2016-2028)
9.2.6.2. Market Revenue and Forecast, By End-Use (2016-2028)
9.3. APAC
9.3.1. Market Revenue and Forecast, By Product (2016-2028)
9.3.2. Market Revenue and Forecast, By End-Use (2016-2028)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, By Product (2016-2028)
9.3.3.2. Market Revenue and Forecast, By End-Use (2016-2028)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, By Product (2016-2028)
9.3.4.2. Market Revenue and Forecast, By End-Use (2016-2028)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, By Product (2016-2028)
9.3.5.2. Market Revenue and Forecast, By End-Use (2016-2028)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, By Product (2016-2028)
9.3.6.2. Market Revenue and Forecast, By End-Use (2016-2028)
9.4. MEA
9.4.1. Market Revenue and Forecast, By Product (2016-2028)
9.4.2. Market Revenue and Forecast, By End-Use (2016-2028)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, By Product (2016-2028)
9.4.3.2. Market Revenue and Forecast, By End-Use (2016-2028)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, By Product (2016-2028)
9.4.4.2. Market Revenue and Forecast, By End-Use (2016-2028)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, By Product (2016-2028)
9.4.5.2. Market Revenue and Forecast, By End-Use (2016-2028)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, By Product (2016-2028)
9.4.6.2. Market Revenue and Forecast, By End-Use (2016-2028)
9.5. Latin America
9.5.1. Market Revenue and Forecast, By Product (2016-2028)
9.5.2. Market Revenue and Forecast, By End-Use (2016-2028)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, By Product (2016-2028)
9.5.3.2. Market Revenue and Forecast, By End-Use (2016-2028)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, By Product (2016-2028)
9.5.4.2. Market Revenue and Forecast, By End-Use (2016-2028)
Chapter 10. Company Profiles
10.1. Boston Scientific Corp.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Teleflex, Inc.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Cardinal Health
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Becton
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Dickinson and Company
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Cook Medical
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. B. Braun Melsungen AG
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Coloplast Group
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Olympus Corp.
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Argon Medical
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Uresil LLC.
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers